From SBA financing and earnouts to equity rollovers, this guide covers the deal structures used in home medical equipment transactions — and how Medicare reimbursement complexity shapes every term.
Acquiring or selling a home medical equipment business requires deal structures that go well beyond a standard asset purchase. Medicare and Medicaid reimbursement rules, payor contract transferability, accreditation continuity, and equipment inventory valuation all create deal-specific risks that must be addressed in how the transaction is financed and documented. Most HME transactions in the $1M–$5M revenue range close as asset purchases using a combination of SBA 7(a) financing, seller notes, and performance-based earnouts. The right structure protects the buyer from reimbursement exposure and billing compliance risk while giving the seller credit for the recurring rental revenue and referral relationships they have built. This guide explains the most common deal structures used in HME acquisitions, what each looks like in practice, and how to negotiate terms that reflect the realities of operating a Medicare-certified DME supplier.
Find Home Medical Equipment Businesses For SaleSBA 7(a) Loan with Seller Note
The most common structure for HME acquisitions in the lower middle market. The buyer secures an SBA 7(a) loan covering 80–90% of the purchase price, injects 10–20% equity, and the seller carries a subordinated note for any gap between the loan proceeds and the agreed purchase price. The seller note is typically on full standby for 24 months per SBA requirements and carries interest rates of 6–8%.
Pros
Cons
Best for: First-time healthcare buyers or independent operators acquiring an established HME business with clean compliance history, active Medicare supplier numbers, and a stable recurring rental revenue base.
Asset Purchase with Payor Contract Retention Earnout
The purchase price is split into a fixed closing payment and a variable earnout component tied to the successful transfer and retention of key payor contracts — particularly Medicare, Medicaid, and major commercial insurance agreements — over a 12–24 month period post-close. This structure directly addresses one of the highest-risk elements of any HME transaction: the uncertainty of whether payor relationships and reimbursement rates survive the ownership change.
Pros
Cons
Best for: Transactions where a significant portion of revenue flows through a concentrated set of payor contracts or where CMS reimbursement rates are subject to renegotiation during the transition period.
Partial Equity Rollover with Seller Retained Stake
The seller retains a 10–20% equity stake in the business post-close while the buyer acquires the controlling interest. The seller typically remains active in a transition or advisory capacity for 12–24 months, supporting referral network continuity, staff retention, and payor contract management. This structure is most common in PE-backed roll-up acquisitions where the seller's relationships with hospital discharge planners and physician referral networks are a critical value driver.
Pros
Cons
Best for: PE-backed roll-up platforms acquiring a regional HME provider where the seller's referral relationships with hospitals, discharge planners, and physicians represent the core of the business's competitive moat.
Independent buyer acquiring a single-location home oxygen and respiratory therapy provider
$2,100,000
SBA 7(a) loan: $1,680,000 (80%) | Buyer equity injection: $210,000 (10%) | Seller note: $210,000 (10%)
Seller note on 24-month SBA standby at 7% interest, then 36-month amortization. Seller provides 6-month full-time transition covering Medicare billing, referral relationships, and staff onboarding. Purchase structured as an asset acquisition including Medicare supplier number, active payor contracts, rental fleet, and customer records.
Regional HME operator acquiring a competitor to expand CPAP and sleep therapy product line
$3,500,000
Cash at close: $2,800,000 (80%) | Earnout: $700,000 (20%) paid over 18 months
Earnout triggered by retention of top 5 commercial payor contracts at existing reimbursement rates and maintenance of at least 85% of recurring rental revenue run rate through month 18. Seller remains employed as Director of Clinical Operations at $90,000 per year during earnout period. Asset purchase structure excludes Medicare overpayment liabilities identified in pre-closing compliance review.
PE-backed HME roll-up platform acquiring a multi-location mobility and wheelchair equipment provider
$4,800,000
Cash at close: $4,080,000 (85%) | Seller equity rollover: $720,000 (15% retained stake)
Seller retains 15% minority interest in the combined platform entity, valued at prevailing platform EBITDA multiple at next liquidity event. Seller joins platform advisory board and manages hospital and skilled nursing facility referral relationships for 24 months. Asset purchase agreement includes specific representations and warranties on ACHC accreditation status, Medicare audit history, and equipment inventory condition with escrow holdback of $240,000 for 12 months to cover indemnification claims.
Find Home Medical Equipment Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
Asset purchases are strongly preferred in HME transactions because they allow the buyer to acquire specific assets — Medicare supplier numbers, payor contracts, equipment inventory, customer accounts — without inheriting the seller's unknown Medicare billing liabilities, past overpayment exposure, or compliance violations. Given the frequency of CMS audits and retroactive recoupment demands in the DME sector, buyers almost always insist on asset purchase structures. Stock purchases may occur in PE-backed deals where tax efficiency and payor contract continuity outweigh the risk, but only after extensive representations and warranties insurance coverage is in place.
Medicare supplier numbers are not directly transferable. When ownership changes in an asset purchase, the buyer must apply for a new Medicare supplier number through the PECOS enrollment system, which can take 60–120 days or longer depending on CMS processing times. During this gap, the business typically cannot bill Medicare under the new ownership. To bridge this period, buyers and sellers often structure a management services agreement or transition services arrangement that allows billing to continue under the seller's number while the buyer's enrollment is pending — a structure that requires careful legal review to ensure compliance with CMS assignment of benefits rules.
In HME transactions, earnouts of 15–25% of purchase price paid over 12–24 months are most common and defensible. The most effective earnouts are tied to specific, measurable metrics: payor contract retention rates, recurring rental revenue as a percentage of pre-close run rate, or continuation of key referral source relationships. Avoid tying earnouts to EBITDA alone, since the buyer controls expenses post-close and can inadvertently — or intentionally — reduce the earnout payout through integration costs. Earnout periods beyond 24 months increase dispute risk significantly and are generally not recommended in lower middle market HME deals.
SBA lenders will finance HME acquisitions, but they scrutinize Medicare and Medicaid compliance history closely. Lenders typically require documentation that there are no open audits, active recoupment demands, or pending exclusions from federal healthcare programs. A clean three-year billing compliance history and current accreditation in good standing are baseline requirements. Some SBA lenders with healthcare lending experience will accept escrow holdbacks or seller indemnifications in lieu of fully resolved minor compliance issues, but material Medicare exposure is generally a deal-stopper for SBA financing and must be resolved before close.
Equipment inventory in an HME business typically includes two categories: rental fleet assets that generate recurring monthly revenue and saleable inventory of disposables, supplies, and retail products. Rental fleet assets are most accurately valued through an independent equipment appraisal that accounts for age, condition, remaining useful life, and replacement cost. Do not rely on book value alone — fully depreciated equipment on the balance sheet may still generate revenue, while assets showing significant book value may require immediate replacement. Buyers should negotiate to exclude aging or non-revenue-generating equipment from the purchase price or use an inventory adjustment mechanism that trues up the final price based on an agreed equipment condition standard at closing.
A 6–12 month seller transition is standard and should be explicitly documented in the purchase agreement. At minimum, the seller should actively support Medicare and Medicaid enrollment transfers, introduce the buyer to key hospital discharge planners, home health agency partners, and physician referral sources, train the buyer on billing workflows and accreditation compliance procedures, and assist in retaining key clinical staff including respiratory therapists and delivery technicians. For businesses where the owner personally manages referral relationships, a 12-month full-time transition with a structured 6-month consulting tail is not unreasonable to request — and for sellers retaining equity, this transition commitment is typically a condition of the rollover structure.
More Home Medical Equipment Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers